7Baggers
 Published on: 2025-10-01 08:07:11  newser.com Wed, 01 Oct 2025 13:07:11 GMT
 promising penny stocks to watch in september 2025  Yahoo Finance Tue, 30 Sep 2025 12:05:02 GMT
 will bdtx's egfr inhibitor bring a paradigm shift in nsclc treatment?  sharewise.com Fri, 26 Sep 2025 09:21:39 GMT
 published on: 2025-09-17 19:43:13  خودرو بانک Wed, 17 Sep 2025 16:16:07 GMT
 is bdtx's cash balance enough to successfully develop its nsclc drug?  sharewise.com Sat, 13 Sep 2025 04:41:25 GMT
 BDTX Stock Surges 51.1% in Six Months: Is There More Room for Growth?  Zacks Investment Research Fri, 05 Sep 2025 14:02:57 GMT
 Is the Recent Pipeline Progress on its NSCLC Drug Enough for BDTX?  Yahoo Finance Thu, 04 Sep 2025 07:00:00 GMT
 black diamond therapeutics initiated with a buy at guggenheim  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-08-30 20:38:27  Newser Sun, 31 Aug 2025 01:38:27 GMT
 published on: 2025-08-30 14:41:25  Newser Sat, 30 Aug 2025 19:41:25 GMT
 published on: 2025-08-29 11:49:21  Newser Fri, 29 Aug 2025 16:49:21 GMT
 published on: 2025-08-28 22:20:20  Newser Fri, 29 Aug 2025 03:20:20 GMT
 published on: 2025-08-28 15:31:25  Newser Thu, 28 Aug 2025 20:31:25 GMT

Black Diamond Therapeutics, Inc
(NASDAQ:BDTX) 

BDTX stock logo

Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies. Its lead product candidate is BDTX-189, an irreversible small molecule inhibitor that is designed to block the function of family of oncogenic proteins defined by driver mutatio...

Founded: 2017
Full Time Employees: 58
CEO: David M. Epstein  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends